Parteck® M - Directly Compressible Mannitol


Our directly compressible mannitol Parteck® M is a good choice for rapid release of high-dose or low-dose active pharmaceutical ingredients (APIs). Developed under Merck's advanced Functional Particle Engineering concept, it is available in two different particle size distributions: Parteck® M 100 and Parteck® M 200.

Benefits of Parteck® M:

  • High compactibility at low compression forces
  • Rapid disintegration and fast dissolution
  • High dilution potential
  • Non-hygroscopic, exceptionally low content of reducing sugars
  • Emprove® documentation and regulatory support
Cat. No.Product DescriptionQuantity
100494 PARTECK® M 100 (Mannitol) suitable for use as excipient EMPROVE® exp Ph Eur,BP,JP,USP,E 421 25 kg
100419 PARTECK® M 200 (Mannitol) suitable for use as excipient EMPROVE® exp Ph Eur,BP,JP,USP,E 421 25 kg
Unique Particle Structure

With its unique particle structure, Parteck® M mannitol allows you to press robust, high-quality tablets with direct compression – no need for prior granulation steps. It is also suitable for low-dose formulation where dose uniformity and mix homogeneity are crucial.

 
 
Webinar: Hot Melt Extrusion with PVA: Overcoming Solubility and Bioavailability Challenges

Webinar
Hot Melt Extrusion with PVA: Overcoming Solubility and Bioavailability Challenges

Watch Now
Your fast track through regulatory challenges. The new Emprove® program. Learn More

Your Fast Track Through Regulatory Challenges.
The Emprove® program.

Learn More